Asphalion CEO Núria Romero and Pharmacovigilance Director Sonia López attended the joint HMA/EMA workshop on Artificial Intelligence in Amsterdam.
The workshop was a fantastic opportunity for stakeholders to provide their views on the priority AI-related topics. The Medicines Regulatory Network (EMRN) has worked on delivering on these priorities, as well as monitoring the rapid evolution of AI tools and techniques and the developing legislative environment.
We´d like to thank all the speakers for their presentations, and HMA & EMA for the smooth organisation!
